Jennison Associates
NBP

Jennison Associates’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Jennison Associates’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-166,485
Closed -$12.1M – 693
2021
Q3 		$12.1M Sell
166,485
-3,775
-2% -$273K 0.01% 431
2021
Q2 		$14.3M Hold
170,260
– – 0.01% 420
2021
Q1 		$8.25M Buy
+170,260
New +$9.24M 0.01% 441

Other funds holding NBP

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates's NBP Position: Q4 2021 in Review

Jennison Associates sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2021, closing a stake of 166,485 shares — an estimated $12.1M sold.

Jennison Associates first reported a position in NBP in Q1 2021 and held it in 3 quarters. The position peaked at $14.3M in Q2 2021. 132 funds tracked by Wall St. Rank hold NBP as of Q4 2021.

  • Jennison Associates reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Jennison Associates sold 166,485 NovaBridge Biosciences American Depositary Shares shares in Q4 2021, an estimated $12.1M.
  • Jennison Associates first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • Jennison Associates's NovaBridge Biosciences American Depositary Shares position peaked at $14.3M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2021.

Based on Jennison Associates's 13F filing for Q4 2021, filed 8 Feb 2022.